Drug Manufacturers - General · Healthcare
Head of Investor Relations
Head of Investor Relations
Johnson & Johnson (JNJ)Equibles does not estimate personal net worth.
Get an email with a short summary when Johnson & Johnson publishes a filing, an earnings call transcript or a press release.
Get JNJ alertsDarren Snellgrove is recorded as Head of Investor Relations at Johnson & Johnson (JNJ). Darren Snellgrove has spoken on 2 earnings calls across 1 company, most recently for Johnson & Johnson on October 14, 2025. Johnson & Johnson is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Johnson & Johnson includes J. Wolk (CFO), D. E. Pinto (Board Member), Daniel Pinto (Board Member) and 7 others.
“Welcome to our 2025 third quarter review of business results and Updated Financial Outlook. First, a few logistics.”
“I am excited to be here today and to lead the Investor Relations team moving forward. Welcome to our 2025 second quarter review of business results and updated financial outlook.”
Drug Manufacturers - General · Healthcare
Head of Investor Relations